Twist Bioscience Enters into Antibody Discovery and Licensing Option Agreement with Bayer of up to $188 Million

Twist Bioscience Corporation , a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced an antibody discovery, option and...

Related Keywords

Facebook Linkedin Youtube ,Emilym Leproust ,Optimization Division Of Twist Bioscience ,Exchange Commission On ,Library Of Libraries ,Twist Biopharma Solutions ,Twist Bioscience Corporation ,Our Library Of Libraries ,Twist Bioscience ,Biologics Discovery ,Optimization Division ,Biopharma Solutions ,Private Securities Litigation Reform Act ,Quarterly Report ,Exchange Commission ,Markets ,